BIOENGINEERING AND MEDTECH AGAINST CANCER
To meet the challenges in healthcare of the 21st century, we need to develop novel approaches by combining Bioengineering and Medtech to cancer diagnosis and prognosis. Each has a role to play in this open innovation model: clinician, engineers, industrials, entrepreneurs, doctors, MedTech companies and, of course, patients.
It’s in this optic, to bring together the different stakeholders and increase collaborations, that the digital oncology short course will take place the 24th and 25th of November 2020 in collaboration with IBEC and the Biocat.
In this context, Medicen Paris Region and Biocat launch a call for expression of interest for a pitch elevator session! The objective is to identify and federate international actors of the oncology field to pitch their innovations in front of renown experts.
Who can participate? Startups, potential entrepreneurs (at the proof of concept stage) and project holders.
Deadline: Application before Friday 2nd of October 2020.